快讯| Editas Medicine Inc - 至少在2027年前提交一个IND/CTA 快讯6分钟前 快讯| Editas Medicine强调新的体内临床前概念数据、预期的2025年关键里程碑和三年战略优先事项 快讯7分钟前 新闻稿:Editas Medicine 强调新的体内临床前概念板块数据、预期2025年的关键里程碑以及三年战略优先事项 Editas Medicine强调了新的体...
How has Editas Medicine, Inc.'s stock performed for the past 5 years? Over the past 5 years, Editas Medicine, Inc.’s stock price has decreased by 95.04%. Editas Medicine, Inc.’s stock price is currently approximately $1.31. View more of Editas Medicine, Inc.’s past performance. ...
EDIT Stock Predictions, Articles, and Editas Medicine, Inc. - Common Stock News 3 Gene Editing Stocks That Could Make Your Grandchildren Rich By Matthew Farley, InvestorPlace Contributor Jun 25, 2024 Explore gene-editing stocks with long-term growth potential, offering innovative solutions to ...
公司名称Editas Medicine 上市日期2016/02/03 发行价格16.00 成立日期2013 CEODr. Gilmore O’Neill, M.B. 所属市场纳斯达克 员工数量265 年结日12-31 公司地址11 Hurley Street 城市Cambridge 省份马萨诸塞州 国家美国 邮编02141 电话1-617-401-9000 网址http://www.editasmedicine.com 董事高管 姓名 职务 年...
Get the latest updates on Editas Medicine, Inc. Common Stock (EDIT) after hours trades, after hours share volumes, and more. Make informed investments with Nasdaq.
Editas Medicine, Inc. (EDIT) growth grade and underlying metrics. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and stocks comparison.
Topics discussed include increase in stock market of biotechnology company Editas Medicine Inc. which offers genome editing technology, medical device Tandem Diabetes Care Inc. increases after its upgraded shares, decrease in Peregrine Pharmaceuticals Inc. after announcing it is discontinuing its trial of...
作者: $Editas Medicine, Inc. Common Stock(EDIT)$已经涨到40,超过了之前所有投资机构的目标价
$Editas Medicine, Inc. Common Stock(EDIT)$ 无可否认,张锋确实是一位生物学领域的天才,关键是他还很年轻,很拼命,有抱负,有商业头脑。同为生物学界的科研人员,张锋确实是我们领域的明星。
Get real-time updates on Editas Medicine, Inc. Common Stock (EDIT) stock quotes, trades, and more. Make informed investments with Nasdaq.